Cargando…
Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience()
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Dermatologia
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984690/ https://www.ncbi.nlm.nih.gov/pubmed/36567165 http://dx.doi.org/10.1016/j.abd.2022.06.003 |
| _version_ | 1784900786137858048 |
|---|---|
| author | Akdaş, Elçin Adışen, Esra Öztaş, Murat Orhan Aksakal, Ahmet Burhan İlter, Nilsel Gülekon, Ayla |
| author_facet | Akdaş, Elçin Adışen, Esra Öztaş, Murat Orhan Aksakal, Ahmet Burhan İlter, Nilsel Gülekon, Ayla |
| author_sort | Akdaş, Elçin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9984690 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Sociedade Brasileira de Dermatologia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99846902023-03-05 Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience() Akdaş, Elçin Adışen, Esra Öztaş, Murat Orhan Aksakal, Ahmet Burhan İlter, Nilsel Gülekon, Ayla An Bras Dermatol Letter - Research Sociedade Brasileira de Dermatologia 2023 2022-12-23 /pmc/articles/PMC9984690/ /pubmed/36567165 http://dx.doi.org/10.1016/j.abd.2022.06.003 Text en © 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Letter - Research Akdaş, Elçin Adışen, Esra Öztaş, Murat Orhan Aksakal, Ahmet Burhan İlter, Nilsel Gülekon, Ayla Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience() |
| title | Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience() |
| title_full | Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience() |
| title_fullStr | Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience() |
| title_full_unstemmed | Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience() |
| title_short | Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience() |
| title_sort | real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience() |
| topic | Letter - Research |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984690/ https://www.ncbi.nlm.nih.gov/pubmed/36567165 http://dx.doi.org/10.1016/j.abd.2022.06.003 |
| work_keys_str_mv | AT akdaselcin reallifeclinicalpracticewithomalizumabin134patientswithrefractorychronicspontaneousurticariaasinglecenterexperience AT adısenesra reallifeclinicalpracticewithomalizumabin134patientswithrefractorychronicspontaneousurticariaasinglecenterexperience AT oztasmuratorhan reallifeclinicalpracticewithomalizumabin134patientswithrefractorychronicspontaneousurticariaasinglecenterexperience AT aksakalahmetburhan reallifeclinicalpracticewithomalizumabin134patientswithrefractorychronicspontaneousurticariaasinglecenterexperience AT ilternilsel reallifeclinicalpracticewithomalizumabin134patientswithrefractorychronicspontaneousurticariaasinglecenterexperience AT gulekonayla reallifeclinicalpracticewithomalizumabin134patientswithrefractorychronicspontaneousurticariaasinglecenterexperience |